<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: GSK&#8217;s Joe Cohen Shares his Excitement about MIM</title>
	<atom:link href="http://mim.globalhealthstrategies.com/blog/?feed=rss2&#038;p=362" rel="self" type="application/rss+xml" />
	<link>http://mim.globalhealthstrategies.com/blog/?p=362</link>
	<description>5th MIM Pan-African Malaria Conference</description>
	<lastBuildDate>Mon, 24 May 2010 18:21:54 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Malaria vaccines: One step forward… Several steps to go &#124;</title>
		<link>http://mim.globalhealthstrategies.com/blog/?p=362&#038;cpage=1#comment-76</link>
		<dc:creator>Malaria vaccines: One step forward… Several steps to go &#124;</dc:creator>
		<pubDate>Fri, 20 Nov 2009 20:15:04 +0000</pubDate>
		<guid isPermaLink="false">http://mim.globalhealthstrategies.com/blog/?p=362#comment-76</guid>
		<description>[...] invented by Dr. Joe Cohen, vice president of Glaxo-SmithKline biologicals.  During the conference, Dr. Cohen addressed a team of journalists about the recently commenced Phase III clinical trials involving this vaccine.  16,000 children [...]</description>
		<content:encoded><![CDATA[<p>[...] invented by Dr. Joe Cohen, vice president of Glaxo-SmithKline biologicals.  During the conference, Dr. Cohen addressed a team of journalists about the recently commenced Phase III clinical trials involving this vaccine.  16,000 children [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
